Physician profile
Henry Slomowitz
NPI 1437243730
$2,755.92
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,937 · 2020: $192 · 2021: $159 · 2022: $106 · 2023: $211 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,372.00 | 2019 | |
| Stryker Corporation | $648.59 | 2019-2024 | Citrefix, Futura Csi |
| Treace Medical Concepts, INC. | $138.14 | 2022-2024 | |
| Cardiovascular Systems INC. | $126.81 | 2019 | |
| Osteomed LLC | $66.68 | 2019 | |
| Boston Scientific Corporation | $63.14 | 2019 | |
| Sebela Pharmaceuticals INC. | $53.36 | 2019-2023 | Pramosone, Naftin |
| Zimmer Biomet Holdings, INC. | $46.71 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.85 | 2022-2024 | Jublia |
| Smith+Nephew, INC. | $43.47 | 2024 | Stravix Pl, Grafix Pl |
| Medshape, INC. | $28.68 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Paratek Pharmaceuticals, INC. | $28.20 | 2022-2023 | Nuzyra |
| Averitas Pharma INC. | $26.96 | 2023-2024 | Qutenza |
| Convatec INC. | $19.47 | 2024 | |
| Organogenesis INC. | $19.46 | 2024 | Puraply Am |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15.47 | 2020 | |
| Novum Pharma, LLC | $14.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Slomowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.